Unusual abdominal tumors

Journal of Clinical Oncology

Volumn 22, Issue 8, 2004, Pages 1518-1520

  Levitz, Jason S ^a,b   Sugarbaker, Paul H ^a,b   Lichtman, Stuart M ^a,b   Brun, Erwin A ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ABDOMINAL TUMOR; APPENDIX TUMOR; ARTICLE; COLLOID CARCINOMA; DIET THERAPY; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PERITONEUM PSEUDOMYXOMA;

ABDOMINAL NEOPLASMS; ADENOCARCINOMA, MUCINOUS; APPENDICEAL NEOPLASMS; DEOXYCYTIDINE; HUMANS; MALE; MIDDLE AGED; PSEUDOMYXOMA PERITONEI;

EID: 2342597786     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2004.05.126     Document Type: Note

References (9)

1. Ronnett BM, Zahn CM, Kurman RJ, et al: Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 19:1390-1408, 1995
2. Jackson SL, Fleming RA, Loggie BW, et al: Gelatinous ascites: A cytohistologic study of pseudomyxoma peritonei in 67 patients. Mod Pathol 14:664-671, 2001
3. Ronnett BM, Yan H, Kurman RJ, et al: Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 92:85-91, 2001
4. Witkamp AJ, de Bree E, Kaag MM, et al: Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 88:458-463, 2001
5. Yan H, Pestieau SR, Shmookler BM, et al: Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: Failure versus success with a second-look operation. Mod Pathol 14:164-171, 2001
6. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727-731, 1999
7. Shen P, Levine EA, Hall J, et al: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin c after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 138:26-33, 2003
8. Van Cutsem E, Peeters M: Developments in fluoropyrimidine therapy for gastrointestinal cancer. Curr Opin Oncol 11:312-317, 1999
9. van Ruth S, Hart AA, Bonfrer JM, et al: Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 9:961-967, 2002